Parmar Arpita, Vandriel Shannon Marie, Ng Vicky Lee
Division of Paediatric Gastroenterology, Hepatology and Nutrition, Transplant and Regenerative Medicine Center, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
Liver Transpl. 2017 Mar;23(3):361-374. doi: 10.1002/lt.24696.
With improved survival rates after pediatric liver transplantation (LT), attention is targeting improving the health-related quality of life (HRQOL) as an outcome metric. We conducted a systematic review of the literature to examine HRQOL after pediatric LT, focusing on assessment tools and factors associated with HRQOL. A literature search was conducted through PubMed, Web of Science, Ovid, and Google Scholar for all studies matching the eligibility criteria between January 2004 and September 2016. Titles and abstracts were screened independently by 2 authors and consensus for included studies was achieved through discussion. A total of 25 (2 longitudinal, 23 cross-sectional) studies were reviewed. HRQOL in pediatric LT recipients is lower than healthy controls, but it is comparable to children with chronic diseases or other pediatric solid organ transplant recipients. Domain scores were lowest in school functioning on the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale 4.0 and general health perception on the Child Health Questionnaire, the 2 most commonly used generic HRQOL instruments. Identified predictors of poor HRQOL include sleep disturbances, medication adherence, and older age at transplantation. Two recently validated disease-specific HRQOL tools, Pediatric Liver Transplant Quality of Life tool and the Pediatric Quality of Life Inventory 3.0 Transplant Module, have enabled enhanced representation of patient HRQOL, when used in conjugation with generic tools. Heterogeneity in study design and instruments prevented a quantitative, meta-analysis of the data. In conclusion, continued optimization of durable outcomes for this population mandates prioritization of research focusing on the gap of targeted intervention studies aimed at specific HRQOL subdomains and longitudinal studies to predict the trajectory of HRQOL over time. Liver Transplantation 23 361-374 2017 AASLD.
随着小儿肝移植(LT)后生存率的提高,人们开始将注意力转向改善与健康相关的生活质量(HRQOL),并将其作为一项结果指标。我们对文献进行了系统回顾,以研究小儿肝移植后的HRQOL,重点关注评估工具以及与HRQOL相关的因素。通过PubMed、科学网、Ovid和谷歌学术对2004年1月至2016年9月期间所有符合纳入标准的研究进行了文献检索。由2位作者独立筛选标题和摘要,并通过讨论就纳入研究达成共识。共回顾了25项研究(2项纵向研究,23项横断面研究)。小儿肝移植受者的HRQOL低于健康对照,但与患有慢性疾病的儿童或其他小儿实体器官移植受者相当。在最常用的两种通用HRQOL工具——儿童生活质量量表(PedsQL)通用核心量表4.0的学校功能领域得分以及儿童健康问卷的总体健康感知得分中,得分最低。已确定的HRQOL较差的预测因素包括睡眠障碍、药物依从性以及移植时年龄较大。两种最近经过验证的疾病特异性HRQOL工具——小儿肝移植生活质量工具和儿童生活质量量表3.0移植模块,与通用工具结合使用时,能够更好地体现患者的HRQOL。研究设计和工具的异质性使得无法对数据进行定量的荟萃分析。总之,要持续优化该人群的持久预后,就必须优先开展研究,重点关注针对特定HRQOL子领域的靶向干预研究差距以及预测HRQOL随时间变化轨迹的纵向研究差距。《肝脏移植》2017年第23卷第361 - 374页 美国肝病研究学会